These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 10403395)

  • 21. Triabodies: single chain Fv fragments without a linker form trivalent trimers.
    Iliades P; Kortt AA; Hudson PJ
    FEBS Lett; 1997 Jun; 409(3):437-41. PubMed ID: 9224705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant single-chain Fv fragments carrying C-terminal cysteine residues: production of bivalent and biotinylated miniantibodies.
    Kipriyanov SM; Dübel S; Breitling F; Kontermann RE; Little M
    Mol Immunol; 1994 Oct; 31(14):1047-58. PubMed ID: 7935496
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancement of scFv fragment reactivity with target antigens in binding assays following mixing with anti-tag monoclonal antibodies.
    Wang X; Campoli M; Ko E; Luo W; Ferrone S
    J Immunol Methods; 2004 Nov; 294(1-2):23-35. PubMed ID: 15604013
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Expression, structure prediction and functional analysis of murine single-chain fragment variable antibody against human cervical cancer].
    Wang Y; Li X; Chen W
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jan; 26(1):16-21. PubMed ID: 16495168
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Construction and characterisation of a functional CD19 specific single chain Fv fragment for immunotherapy of B lineage leukaemia and lymphoma.
    Nicholson IC; Lenton KA; Little DJ; Decorso T; Lee FT; Scott AM; Zola H; Hohmann AW
    Mol Immunol; 1997; 34(16-17):1157-65. PubMed ID: 9566763
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Construction and expression of single-chain Fv antibody against human VEGF].
    Wang D; Yang X; Yuan Q
    Zhonghua Yi Xue Za Zhi; 2000 Jul; 80(7):526-9. PubMed ID: 11798812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant anti-sialidase single-chain variable fragment antibody. Characterization, formation of dimer and higher-molecular-mass multimers and the solution of the crystal structure of the single-chain variable fragment/sialidase complex.
    Kortt AA; Malby RL; Caldwell JB; Gruen LC; Ivancic N; Lawrence MC; Howlett GJ; Webster RG; Hudson PJ; Colman PM
    Eur J Biochem; 1994 Apr; 221(1):151-7. PubMed ID: 8168505
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ScFv multimers of the anti-neuraminidase antibody NC10: shortening of the linker in single-chain Fv fragment assembled in V(L) to V(H) orientation drives the formation of dimers, trimers, tetramers and higher molecular mass multimers.
    Dolezal O; Pearce LA; Lawrence LJ; McCoy AJ; Hudson PJ; Kortt AA
    Protein Eng; 2000 Aug; 13(8):565-74. PubMed ID: 10964986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dimeric and trimeric antibodies: high avidity scFvs for cancer targeting.
    Kortt AA; Dolezal O; Power BE; Hudson PJ
    Biomol Eng; 2001 Oct; 18(3):95-108. PubMed ID: 11566601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibody engineering of a cytotoxic monoclonal antibody 84 against human embryonic stem cells: Investigating the effects of multivalency on cytotoxicity.
    Klement M; Zheng J; Liu C; Tan HL; Wong VV; Choo AB; Lee DY; Ow DS
    J Biotechnol; 2017 Feb; 243():29-37. PubMed ID: 28042013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of antibody framework residue VH-71 on the stability of a humanised anti-MUC1 scFv and derived immunoenzyme.
    Krauss J; Arndt MA; Zhu Z; Newton DL; Vu BK; Choudhry V; Darbha R; Ji X; Courtenay-Luck NS; Deonarain MP; Richards J; Rybak SM
    Br J Cancer; 2004 May; 90(9):1863-70. PubMed ID: 15150594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficient construction of a diabody using a refolding system: anti-carcinoembryonic antigen recombinant antibody fragment.
    Asano R; Kudo T; Nishimura Y; Makabe K; Hayashi H; Suzuki M; Tsumoto K; Kumagai I
    J Biochem; 2002 Dec; 132(6):903-9. PubMed ID: 12473192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics and biodistribution of genetically-engineered antibodies.
    Colcher D; Pavlinkova G; Beresford G; Booth BJ; Choudhury A; Batra SK
    Q J Nucl Med; 1998 Dec; 42(4):225-41. PubMed ID: 9973838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Production of functionalized single-chain Fv antibody fragments binding to the ED-B domain of the B-isoform of fibronectin in Pichia pastoris.
    Marty C; Scheidegger P; Ballmer-Hofer K; Klemenz R; Schwendener RA
    Protein Expr Purif; 2001 Feb; 21(1):156-64. PubMed ID: 11162401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bispecific tandem diabody for tumor therapy with improved antigen binding and pharmacokinetics.
    Kipriyanov SM; Moldenhauer G; Schuhmacher J; Cochlovius B; Von der Lieth CW; Matys ER; Little M
    J Mol Biol; 1999 Oct; 293(1):41-56. PubMed ID: 10512714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conformational stability, folding, and ligand-binding affinity of single-chain Fv immunoglobulin fragments expressed in Escherichia coli.
    Pantoliano MW; Bird RE; Johnson S; Asel ED; Dodd SW; Wood JF; Hardman KD
    Biochemistry; 1991 Oct; 30(42):10117-25. PubMed ID: 1931943
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibodies specific for (6-4) DNA photoproducts: cloning, antibody modeling and construction of a single-chain Fv derivative.
    Morioka H; Miura H; Kobayashi H; Koizumi T; Fujii K; Asano K; Matsunaga T; Nikaido O; Stewart JD; Ohtsuka E
    Biochim Biophys Acta; 1998 Jun; 1385(1):17-32. PubMed ID: 9630483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variable region sequence modulates periplasmic export of a single-chain Fv antibody fragment in Escherichia coli.
    Ayala M; Balint RF; Fernández-de-Cossío L; Canaán-Haden JW; Larrick JW; Gavilondo JV
    Biotechniques; 1995 May; 18(5):832, 835-8, 840-2. PubMed ID: 7619489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sequence analysis of a monoclonal antibody specific for the preS2 region of hepatitis B surface antigen, and the cloning, expression and characterisation of its single-chain Fv construction.
    Passafiume M; Vulliez-le Normand B; Riottot MM; Bentley GA
    FEBS Lett; 1998 Dec; 441(3):407-12. PubMed ID: 9891981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficient generation of respiratory syncytial virus (RSV)-neutralizing human MoAbs via human peripheral blood lymphocyte (hu-PBL)-SCID mice and scFv phage display libraries.
    Nguyen H; Hay J; Mazzulli T; Gallinger S; Sandhu J; Teng Y; Hozumi N
    Clin Exp Immunol; 2000 Oct; 122(1):85-93. PubMed ID: 11012623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.